You can narrow down the results using the filters
-
Type 1 Diabetes National Screening Pilot: Monitoring Children with Early Stage Type 1 Diabetes
Expand descriptionType 1 diabetes is a lifelong autoimmune condition characterised by high blood glucose levels. Children with early stage type 1 diabetes (defined as two or more (multiple) islet antibodies, Stage 1-2 type 1 diabetes) or at-risk of the condition (defined as a single antibody, pre-type 1 diabetes) require ongoing clinical monitoring for disease progression and to avoid life-threatening complications arising from late recognition of symptom onset and insulin requirement (i.e. Stage 3 type 1 diabetes). This study is a follow-on from The Type 1 Diabetes National Screening Pilot: Feasibility and Acceptability Study. It aims to include up to 36 children with type 1 diabetes antibodies, detected via screening, to evaluate the feasibility and acceptability of the international clinical guidelines for ongoing monitoring of children with early stage- or pre- type 1 diabetes.
-
ZOvCa: A phase 1 Positron Emission Tomography (PET) - Computed Tomography (CT) study to evaluate the safety, biodistribution and pharmacokinetics of 89Zr-hu/mo-10D7 in patients with advanced epithelial Ovarian Cancer
Expand descriptionThis study aims to evaluate the safety, biodistribution and pharmacokinetics of 89Zr-hu/mo-10D7 to detect known tumour deposits in patients with advanced epithelial Ovarian Cancer. Who is it for? You may be eligible for this study if you are an adult with recurrent, histologically proven advanced ovarian cancer with a macroscopically visible tumour on diagnostic imaging. Study Details All participants who meet the eligibility criteria in this study will receive a single dose of 89Zr-hu/mo-10D7 as an intravenous infusion over 30 minutes to delivery maximum dose of 4.5 mg protein and 37 MBq radiation. During and after completion of the treatment participants will be assessed for safety, biodistribution and pharmacokinetics of 89Zr-hu/mo-10D7 via vital signs, blood tests, ECG, urinalysis and PET/CT scan. It is hoped that this research project will demonstrate hu/mo-10D7 targets advanced ovarian cancer metastases in humans and therefore prove its potential utility as a theranostic in ovarian cancer.
-
Faecal microbiota transplantation for primary sclerosing cholangitis Sub-study: Profiling the portal vein in primary sclerosing cholangitis
Expand descriptionPrimary sclerosing cholangitis (PSC) is a rare and chronic liver disease with no current effective medical treatment options. Patients with PSC are at high risk of bile duct cancer, recurrent sepsis, and many progress to liver transplantation within 10 years. Patients with PSC have an abnormal gut microbiota and current evidence suggests that manipulation of the gut microbiota holds promise as a therapeutic strategy in PSC. The proposed study is investigating whether faecal microbiota transplantation (FMT) from healthy donors, delivered via lyophylised (freeze-dried) capsules, is safe for patients with PSC. The study will also seek signals for efficacy in terms of improving liver function tests and liver duct changes visible on imaging. Participants who choose to enrol in the sub-study will undergo endoscopic-ultrasound guided portal vein sampling at the time of their baseline and week 24 colonoscopies. The sub-study aims to identify the composition and function of the microbiota of the portal venous system and their products, and to explore how this is altered by FMT. This may reveal important pathogenic links between the gut and the liver in PSC, which can be used to develop future therapies.
-
A Seven Day Study of the SynerG Combined Insulin-Delivery and Glucose Sensory System in Persons with Type 1 Diabetes
Expand descriptionThis study will evaluate the accuracy of an experimental CGM measuring glucose continuously in the immediate vicinity of subcutaneous insulin delivery in people with type 1 diabetes (T1D) on insulin pump therapy. Glucose sensory accuracy will be measured over a 7 days period, along with device survival and tolerability over the same period. Accuracy of the device will be tested in both a free living state, as well as over three seperate mixed meal challenges in order to test the device accuracy over a range of glucose levels.
-
The Paediatric Obstructive Sleep Apnoea (OSA) Screening Triple Test (POSTT) Study: Validation of a novel home delivered paediatric OSA screening test.
Expand descriptionObstructive sleep apnoea (OSA) has serious negative impacts to the physical health, mental health, and cognitive function and development of children. Unfortunately, OSA is quite common and is reported to occur between 1-6% of children. However, currently, the gold standard for OSA assessment (a sleep study or polysomnography (PSG)) is expensive and difficult to access. The limited access to PSG testing leads to unnecessary risk for these children, as it often delays in treatment, and/or results in an incomplete assessment prior to surgeries like adenotonsillectomy. However, a novel postage delivered and home conducted kit may be able to reduce these issues. The Paediatric OSA Screening Triple Test (POSTT) is TGA approved and includes an overnight oximetry device, a validated sleep questionnaire, and video tonsil assessment tool. This proposed research will compare the novel POSTT kit to PSG and determine the diagnostic accuracy, real-world feasibility, and patient satisfaction and preference. We hypothesise that the POSTT kit will demonstrate to be as accurate and more feasible than PSG. If the hypothesise is correct, the novel kit will allow for an increase in access to care, especially for regional and rural patients.
-
Evaluation of the effect of positioning in neonates with Congenital Diaphragmatic Hernia.
Expand descriptionCongenital diaphragmatic hernia (CDH) is a condition requiring immediate medical and multidisciplinary management, including physiotherapy. Positioning is a commonly used physiotherapy technique supported by the literature. However, the extent of its improvement on the respiratory system is unknown due to the limitations of the measuring equipment. Current measuring tools lack the ability to detect regional changes in the lungs. Electrical impedance tomography (EIT) has shown to be safe and effective in other areas of the healthcare system but has not been used for infants with CDH. This study will use EIT to assess the effectiveness of positioning in infants with CDH.
-
Investigating the ability of Systems Thinking with Active Implementation (STAIR) to create healthy school environments: an effectiveness-implementation trial
Expand descriptionSociety asks a lot of schools, including that they protect children's health and wellbeing. This trial will work out the best way of supporting schools, teachers and school communities to create and sustain school environments that protect children's physical and mental health. We will measure the impact and return on investment of this support on children's health and education outcomes as well as on the schools themselves.
-
Supporting Mothers in Regional NSW: A Telehealth Intervention for Birth Trauma
Expand descriptionFor most women, childbirth is a significant life event that can be associated with a range of emotional responses, from joy and relief for some, but trauma and distress for others. A traumatic childbirth experience, sometimes referred to as ‘birth trauma’ lead to poor mental health outcomes in postpartum women, severely impacting mother-infant attachment, child development, and overall mental health of the family unit. The current project will be the first intervention for postpartum mothers with recent traumatic birth experiences, to decrease serious and persistent mental health concerns. This project will assess the feasibility and acceptability of a highly innovative telehealth group-based early intervention for this vulnerable population group.
-
Embedding digitally enabled, single case experiments in general practice to support self-management and shared decision-making with patients with persistent pain
Expand description -
Vaginal Laser therapy for Treatment of Stress Urinary Incontinence
Expand descriptionThe aim of this study is to evaluate the use of Er:YAG laser treatment as a potential treatment for women with slight to severe stress urinary inconctinence. We hypothesize that Er:YAG Laser is superior to sham therapy in women who have slight to severe stress urinary incontinence, based on the Severity Index for Urinary Incontinence in women, with subjective improvement rates defined as a Minimal Important Difference (MID) of 4 points on the ICIQ-UI-SF questionnaire.